PhenoSwitch Bioscience is now Allumiqs.


Kent MacLean

Chief Executive Officer & Director

A senior business development leader and visionary, Kent joined Allumiqs (formerly Proteoform Scientific) in 2018 to fully commercialize the company and lead strategic growth initiatives.

Kent brings more than 30 years of global experience in finance, operations, and business development to the company. With in-depth knowledge and hands-on experience in both start-up and high-growth organizations in Canada, the United States, Caribbean, and Latin America, Kent has a proven track record in accelerated business achievements.

Kent focuses on creating highly effective teams, expanding international markets, developing and nurturing key profitable business networks, and securing long-term client and partner relationships built on trust, which all contribute to successful business ventures.

Back to team